In this study, we used bioinformatics to explore the expression levels and mutations of USP45 in different types of tumor and their correlation with patient prognosis, mRNA methylation, tumor heterogeneity, tumor stemness, and tumor immunity. This evidence concerns the gene USP45 and neoplasm.